	US 12,138,237 B2
	Compositions comprising N-Acetyl Methyl GABA and related methods
Ned L. Jensen, Alpine, UT (US)
Assigned to MBI Distributing, Lindon, UT (US)
Filed by MBI Distributing, Lindon, UT (US)
Filed on Jul. 25, 2023, as Appl. No. 18/358,062.
Application 18/358,062 is a division of application No. 17/245,861, filed on Apr. 30, 2021, granted, now 11,957,653.
Claims priority of provisional application 63/018,185, filed on Apr. 30, 2020.
Prior Publication US 2024/0041815 A1, Feb. 8, 2024
Int. Cl. A61K 31/4045 (2006.01); A61K 9/127 (2006.01); A61K 31/22 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61K 47/24 (2006.01); A61P 15/00 (2006.01); A61P 25/06 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 25/28 (2006.01); C07C 231/14 (2006.01)

CPC A61K 31/22 (2013.01) [A61K 9/127 (2013.01); A61K 31/4045 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/24 (2013.01); A61P 15/00 (2018.01); A61P 25/06 (2018.01); A61P 25/20 (2018.01); A61P 25/22 (2018.01); A61P 25/28 (2018.01); C07C 231/14 (2013.01)]

18 Claims

1. A method of aiding sleep and/or treating insomnia in a subject comprising the steps of:

a. providing a composition comprising N-Acetyl Methyl GABA; and

b. administering the composition to the subject before a sleep period in an amount effective to increase the amount of N-Acetyl Methyl GABA in the subject's bloodstream and brain tissue during the subject's sleep period to aid sleep and/or treat insomnia;

wherein said increased amount of N-Acetyl Methyl GABA in the subject's bloodstream and tissue improves the subject's sleep quality during the subject's sleep period compared with sleep periods without the N-Acetyl Methyl GABA, and/or provides good to excellent sleep quality during the sleep period.